Nov 25, 2021 Mydecine Innovations Group Named Among Business Worldwide Magazine's List of Top 20 Most Innovative Companies to Watch
Nov 22, 2021 Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Excited for Seamless Phase 2/3 Clinical Research as Dr. Matthew Johnson Presents Interim Results of Current Smoking Cessation Study at the Psychedelic Medicine Business Event: Wonderland
Nov 4, 2021 Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leader in Emerging Psychedelic-Assisted Psychotherapy Industry
Nov 2, 2021 Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Part of Psychedelic Medicine Research Renaissance
Nov 2, 2021 BioMedNewsBreaks - Why Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Is 'One to Watch'
Oct 5, 2021 Mydecine Innovations reports positive pre-clinical data for MYCO-003 and updates on patent progress
Jan 27, 2021 Co-founder and CEO Josh Bartch Sees a Big Future for Psilocybin and Other Mushroom-based Compounds in Both Pharmaceuticals and Consumer Packaged Goods
Jan 20, 2021 Co-founder and CEO Josh Bartch Sees a Big Future for Psilocybin and Other Mushroom-based Compounds in Both Pharmaceuticals and Consumer Packaged Goods